61 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

NTRA

Natera
US$110.20-0.9%119.3%US$13.5bUS$123.50PS11.2xE69.9%n/a

NUVL

Nuvalent
US$77.78-1.8%79.8%US$5.0bUS$99.67PB7.4xE-0.5%n/a

DYN

Dyne Therapeutics
US$33.076.9%202.0%US$3.3bUS$45.90PB6.9xE19.9%n/a

IMVT

Immunovant
US$26.003.3%29.4%US$3.8bUS$49.14PB6.1xE47.8%n/a

DCPH

Deciphera Pharmaceuticals
US$25.590.08%76.5%US$2.2bUS$26.85PS12.7xE50.6%n/a

DNLI

Denali Therapeutics
US$20.73-0.2%-33.2%US$3.0bUS$38.67PS10xE11.2%n/a

SWTX

SpringWorks Therapeutics
US$38.55-4.2%40.3%US$2.9bUS$65.92PS107.9xE47.9%n/a

OLK

Olink Holding
US$24.850.8%39.5%US$3.1bUS$26.00PS18.1xE165.4%n/a

IMGN

ImmunoGen
US$31.236.6%617.9%US$8.4bUS$28.95PS29.1xE45.8%n/a

GPCR

Structure Therapeutics
US$48.17-9.2%50.6%US$2.2bUS$83.10PB5.2xE-21.9%n/a

BHVN

Biohaven
US$33.830.6%43.0%US$2.9bUS$57.89PB9.9xE8.1%n/a

CRNX

Crinetics Pharmaceuticals
US$45.331.4%123.1%US$3.6bUS$67.50PS1810.9xE10.6%n/a

MRNA

Moderna
US$140.03-7.3%8.8%US$53.7bUS$145.17PS10.4xE67.6%n/a

MYGN

Myriad Genetics
US$23.204.8%1.3%US$2.1bUS$25.09PS2.7xE66.8%n/a

TPTX

Turning Point Therapeutics
US$76.011.3%18.9%US$3.8bUS$76.00PS3776xE24.7%n/a

JANX

Janux Therapeutics
US$42.00-4.9%234.1%US$2.2bUS$63.13PS298.8xE-16.6%n/a

CLDX

Celldex Therapeutics
US$34.67-1.7%-2.8%US$2.3bUS$66.43PS376.3xE11.8%n/a

ALPN

Alpine Immune Sciences
US$64.970.03%518.2%US$4.5bUS$62.00PS78.9xE-9.9%n/a

RVMD

Revolution Medicines
US$38.62-4.3%56.9%US$6.4bUS$44.82PS1395.5xE10.4%n/a

ILMN

Illumina
US$108.66-4.4%-47.2%US$17.3bUS$152.09PS3.9xE67.3%n/a

TXG

10x Genomics
US$20.25-7.4%-65.2%US$2.4bUS$40.00PS3.9xE63.4%n/a

RNA

Avidity Biosciences
US$39.6449.0%227.1%US$4.2bUS$62.25PS387.2xE27.7%n/a

RXDX

Prometheus Biosciences
US$199.920.5%684.3%US$9.6bUS$194.29PS2392.6xE12.1%n/a

CBAY

CymaBay Therapeutics
US$32.480.03%262.9%US$3.7bUS$32.50PS120xE54.8%n/a
Page 2 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.